QTAS

QTAS revolutionizes cancer therapy monitoring with quantum sensing-based liquid biopsy from whole blood - delivering results 25x faster and 10x cheaper than current methods.

QTAS operates in deeptech.

Within the deeptech space, the company focuses on its core offering rather than a broad product line.

Directory data places it at the UnternehmerTUM Accelerator portfolio company stage.

Website: qtas.io